Plan B
This article was originally published in The Tan Sheet
Executive Summary
Label comprehension study analysis expected by early September, after which actual use study will begin in preparation for switch NDA, Women's Capital Corp. says Aug. 1. Firm also will gather post-marketing surveillance data on nonprescription emergency contraceptive use in Europe and British Columbia along with data from U.S. pilot programs. A behavioral study on EC use underway by UC-San Francisco researchers, who began recruitment in July (1"The Tan Sheet" Jan 1, p. 12). Label comp study expected to end in late 2001, with switch application planned for early summer 2002